OR WAIT null SECS
© 2022 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2022 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
August 13, 2020
A compilation of recent notable news developments that pertain to the clinical trials industry.
Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
The increasing need for treatments to slow the global spread of COVID-19 has prompted greater cooperation between drug regulatory authorities around the world.
July 24, 2020
While there's been hopeful news on treatments and vaccines, sponsors should plan to discuss necessary strategies and contingencies at the outset of new studies or re-opening of halted studies during the COVID-19 pandemic.
A first vaccine against this coronavirus could still take some time to develop, but mRNA vaccine platforms could offer an early breakthrough.
Over the past few years, there has been significant growth in the use of more complex point of care laboratory devices.
July 22, 2020
An amendment to Pediatric Research Equity Act, as part of the 2017 FDA Reauthorization Act, goes into effect soon aiming to change the landscape and promote pediatric cancer drug development.
July 17, 2020
Understanding how your strategy will be re-shaped post-COVID.
July 13, 2020
In the third of their survey series, Clinical SCORE uncover the specific hurdles faced by site staff and trial participants during the COVID-19 pandemic and the support needed to overcome them.
To overcome sponsor-related challenges and work to successfully secure more trials, there are tactical steps CROs can take.